Market News AIOpen the app

APVO stock news · Aptevo Therapeutics Inc.

Stories about Aptevo Therapeutics Inc. (APVO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for APVO

Follow Aptevo Therapeutics Inc. (APVO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for APVO
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 8:38 AM ET · Market

    Aptevo Therapeutics Inc.: Other Events (APVO)

    Good for APVO

    Aptevo reported a substantial reduction in infusion-related reactions after refining mipletamig’s priming-dose plan. This is favorable because fewer reactions may make treatment easier to receive.

  2. Oct 14, 2026, 9:56 AM ET · Market

    Aptevo Therapeutics Inc. says it will show off its multispecific platform at a big meeting in November 2026.

    Neutral

    Aptevo said its multispecific platform will be presented at a cancer-immunotherapy meeting in November. The filing gives no study results or business change, so it does not change the company's outlook.

  3. Sep 3, 2026, 1:23 PM ET · Market

    Thursday's intraday session sees significant fluctuations in 12 health care stocks.

    Bad for APVO

    Shares fell 21.55% during the session, indicating negative near-term sentiment.